BWM
GILD icon

BlackDiamond Wealth Management’s Gilead Sciences GILD Stock Holding History

BlackDiamond Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$311K Sell
2,335
-32
-1% -$4.22K 0.12% 164
2026
Q1 		$330K Buy
2,367
+637
+37% +$89.2K 0.16% 127
2025
Q4 		$262K Sell
1,730
-532
-24% -$64.7K 0.13% 163
2025
Q3 		$251K Buy
2,262
+431
+24% +$49K 0.14% 148
2025
Q2 		$205K Buy
+1,831
New +$195K 0.12% 159

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackDiamond Wealth Management's GILD Position: Q2 2026 in Review

BlackDiamond Wealth Management reduced its Gilead Sciences (GILD) stake by 1.4% in Q2 2026, selling an estimated $4.22K and leaving 2,335 shares worth $311K. The position accounts for 0.12% of the portfolio, ranked #164.

BlackDiamond Wealth Management first reported a position in GILD in Q2 2025 and has held it in 5 quarters since. The position peaked at $330K in Q1 2026. 2,285 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • BlackDiamond Wealth Management held 2,335 shares of Gilead Sciences worth $311K as of Q2 2026.
  • BlackDiamond Wealth Management sold 32 Gilead Sciences shares in Q2 2026, an estimated $4.22K.
  • Gilead Sciences made up 0.12% of BlackDiamond Wealth Management's portfolio in Q2 2026, its #164 holding.
  • BlackDiamond Wealth Management first reported a position in Gilead Sciences in Q2 2025 and has held it in 5 quarters since.
  • BlackDiamond Wealth Management's Gilead Sciences position peaked at $330K in Q1 2026.
  • 2,285 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on BlackDiamond Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.